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Two pancreatic peptides, somatostatin-28 and peptide YY, have been isolated from the Brockmann bodies 
of the teleost fish Cottus scorpius (daddy sculpin). Following purification by reverse-phase HPLC, each pep- 
tide was sequenced completely through to the carboxyl-terminus by gas-phase Edman degradation. Soma- 
tostatin-28 was the major form of somatostatin detected and is similar to the gene II product from angler- 
fish. Peptide YY (36 amino acids) more closely resembles porcine neuropeptide YY and intestinal peptide 
YY than it does the pancreatic polypeptides. 
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1. INTRODUCTION 
Protein sequence analysis of pancreatic hor- 
mones from different species not only provides the 
basis for understanding structure-activity relation- 
ships but also, in conjunction with cDNA sequence 
data, may show the way in which the precursor 
(prohormone) molecules are processed. The islet 
organs (Brockmann bodies) from certain of the 
teleost fish are a particularly rich source of the 
pancreatic hormones - insulin, glucagon, 
somatostatin and pancreatic polypeptide [ 1,2]. In 
these species (e.g., catfish, anglerfish, salmon), it 
is apparent that somatostatin can exist in several 
forms [3-71, evidently derived from two distinct 
genes (I and II) and also containing various N- 
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Pancreatic polypeptide has been identified in a 
wide variety of vertebrate species, and isolated and 
characterised from mammals, birds, and reptiles 
[g-11]. It is a 36 amino acid peptide with an 
amidated C-terminus, containing (thus far) 9 con- 
served residues. Similar peptides have been 
characterised from porcine brain (NPY) and in- 
testine (PYY) [12,13] while a non-amidated 37 
amino acid form was recently found in anglerfish 
Brockmann bodies [14]. The crystal structure of 
avian PP has been determined, and suggests that a 
common three-dimensional structure could accom- 
modate the quite extensive sequence variation seen 
in this family of peptides 1151. 
Abbreviations: HPLC, high performance liquid We recently isolated a PP-like peptide along 
chromatography; PTH, phenylthiohydantoin; PP, pan- with the other pancreatic hormones, from the islet 
creatic polypeptide; NPY, neuropeptide YY; PYY, in- organs of the teleost fish, Cottus scorpius (daddy 
testinal peptide YY; aPY, anglerfish pancreatic peptide sculpin) [ 161. The complete amino acid sequence of 
YG; SPY, sculpin pancreatic peptide YY insulin was determined as well as a partial sequence 
terminal extensions to the 14 amino acid ‘parent’ 
peptide, S-14. The S-14 I form is identical to that 
found in higher order species [8] whereas the larger 
forms (S-22, S-25, S-28) derived from gene II are 
probably terminal products of prosomatostatin 
processing, and appear to have modified biological 
activities compared to S-14 I [7]. 
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for the PP-like molecule. This paper reports the 
complete amino acid sequence of this molecule and 
also that of somatostatin. 
2. MATERIALS AND METHODS 
The pancreatic hormones were extracted from 
Brockmann bodies of daddy sculpin, freshly 
caught at the Kristineberg Marine Biology Station 
(Fiskebackskil, Sweden) as described [16]. Gel 
filtration yielded an absorbance peak of A& about 
4000-6000 which ‘was further fractionated by 
reverse-phase HPLC (Waters BBondapak alkyl- 
phenyl) in 50 mM ammonium acetate/acetonitrile 
[ 161. Individual peaks were re-chromatographed 
on a Waters-Millipore liquid chromatograph using 
a Brownlee Aquapore RP-300 column (30 x 
4.6 mm) and a 0.1% trifluoroacetic acid/acetoni- 
trile gradient (fig. 1). Absorbance was monitored at 
both 214 and 280 nm. Appropriate fractions were 
reduced in volume under a stream of nitrogen 
before being submitted for sequence analysis. 
Amino acid sequence analysis was carried out on 
a model 470A gas phase sequencer with an on-line 
model 120A PTH analyser (Applied Biosystems, 
Foster City, CA). For the PP-related material two 
separate experiments were performed. The first 
used 60 pmol peptide and yielded sequence infor- 
mation up to cycle 21. The second, using 
700 pmol, employed a customised programme for 
Pro and Ser/Thr at the appropriate sites known 
from the first run and enabled the complete se- 
quence of 36 residues to be determined. In the case 
of somatostatin, 1100 pmol of unreduced peptide 
was sequenced to completion. 
C-terminal analysis on the PP-like molecule was 
attempted using carboxypeptidase Y (EC 3.4.16.1) 
under conditions established as being successful 
for other peptides possessing unmodified carboxy- 
termini. The enzyme/substrate ratio used was 1: 25 
(w/w), twice the concentration of enzyme used in 
these control experiments. Amino acid analysis 
was carried out using the Waters-Millipore system 
described in [ 161. 
3. RESULTS AND DISCUSSION 
Previously we had isolated, by gel filtration and 
reverse-phase HPLC, four distinct fractions from 
sculpin islet tissue, three of which were identified 
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as glucagon, insulin and PP, respectively [16]. The 
fourth fraction, which eluted between insulin and 
the PP-like peptide on HPLC, has now been iden- 
tified by sequencing as somatostatin-28. The PP- 
like peptide has also been sequenced and by 
analogy with other peptides in this family [14,17] 
is referred to as sculpin,pancreatic peptide YY, or 
SPY, to denote the N-terminal and C-terminal 
tyrosine residues. 
The final purification of the peptides was 
achieved by an additional reverse-phase HPLC 
step as shown in fig.1. The yield of 
somatostatin-28 was approx. 0.12 mg/g tissue, 
whereas that for SPY was 0.16 mg/g tissue. The 
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Fig.1. Final purification by reverse-phase HPLC of the 
somatostatin and PP-like peptide from the islet organs 
of the daddy sculpin. The peptides were eluted using a 
30 min gradient, from 15 to 45% acetonitrile in O.lqo 
trifluoroacetic acid, at a flow rate of 1 ml/min. The 
inset shows prior separation of sculpin pancreatic 
peptides by HPLC as described in [16]. Peaks G, I, S 
and P refer to fractions containing lucagon, insulin, 
somatostatin and PP-like peptide, respectively. 
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unambiguous identification at each cycle of the se- 
quence analyses testified to the homogeneity of the 
peptides, and could be continued through to the C- 
terminus. Yields at each cycle are shown in fig.2. 
Assignment of half-cystine to positions 17 and 28 
in somatostatin-28 was made on the basis of (i) 
lack of a detectable PTH derivative because of the 
disulphide link between these positions, (ii) the 
presence of two cysteic acid residues from amino 
acid analysis of a performic acid treated sample, 
and (iii) analogy with all known somatostatin 
molecules. Amino acid analysis confirmed the se- 
quence assignments made for the two peptides. 
The PTH derivative of terminal residue 36 of 
SPY co-eluted with PTH-tyrosine. However it is 
known that all members of the PP family except 
anglerfish PY possess an amidated C-terminus at 
position 36 due to the presence of an obligatory 
glycine residue at position 37 in the unprocessed 
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Fig.2. Sequence information for sculpin somatostatin 
(S-28) and pancreatic peptide YY (SPY). No yield is 
reported for Cys-17 and Cys-28 of somatostatin as the 
disulphide bridge between them remained intact during 
sequencing. 
peptide [ 181. The anglerfish peptide retains Gly-37 
[14]. As there was insufficient material to confirm 
the presence of an amidated tyrosine by the usual 
dansyl method [ 191 and because PTH- 
tyrosinamide and PTH-tyrosine standards co-elute 
under the conditions used for sequence analysis, 
support was provided by the carboxypeptidase Y
experiment which showed no release of tyrosine 
over 24 h under conditions established as being 
favourable. 
3.1. Somatostatin 
The somatostatin characterised in this study is 
an S-28 type, similar to that found in anglerfish 
islet tissue (designated S-28 II), in which the C- 
terminal tetradecapeptide shows two sequence 
changes (Tyr-21 and Gly-24) from standard mam- 
malian S-14 I. It is possible that other forms of 
somatostatin may also be present, as found in 
Coho salmon [7] where S-14 I, S-14 II and S-25 II 
have all been identified. The latter is the major 
form detected in salmon islet tissue and is clearly 
homologous to the sculpin S-28 and anglerfish 
S-28 II sequences, particularly when the tripeptide 
deletion is adjusted for (table 1). The isolation and 
characterisation of sculpin S-28 lends support to 
the notion that gene II prosomatostatin is pro- 
cessed differently from that of gene I in the en- 
docrine pancreas of teleost fish, i.e., more directed 
towards production of the extended forms of 
somatostatin. 
Overall, considerable sequence variation is seen 
in the N-terminal sequences of the S-28 forms of 
somatostatin but this does not necessarily preclude 
a defined structural role for this section, such as 
the &turn thought to be necessary for correct pro- 
teolytic processing at the N-terminus [20]. The 
presence of Pro-4 and Pro-5 in sculpin S-28 is com- 
patible with this view; they may also compensate 
for the substitution of Pro to Leu at position 10. 
Alternatively, the biological role of S-28 itself may 
depend crucially on this early sequence. 
3.2. Pancreatic peptide YY (SPY) 
This peptide, clearly related to the so-called pan- 
creatic polypeptides, is known to exist only in the 
pyloric and not the splenic Brockmann body of the 
daddy sculpin [21]. It turns out to be, not surpris- 
ingly, similar to aPY from anglerfish except for the 
C-terminus which is incompletely processed in the 
59 
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Table 1 
Comparison of the amino acid sequences of the extended forms of somatostatin (upper panel) and of the pancreatic 
polypeptide family (lower panel) 
5 10 15 20 25 
Sculpin S-28 SVDPPNNIPLRERKAGCKNFYWKGFTSC 
Anglerfish S-28 II - - - ST--L-P------__--_-----__ 
Salmon S-25 SVD_L-P------___-_------- 
Anglerfish S-28 I AASGGPLLAP____---___F__T_--- 
Porcine S-28 -ANSNPAMAP____------F-_T___- 
Catfish S-22 II DNTVTSKPLN-M-.YF--SR-A- 
5 10 15 20 25 30 35 
Sculpin SPY YPPQPESPGGNASPEDIJAKYHAAVRHYVNLITRQRY-NH, 
Anglerfish aPY --- K__T__s_-------s-Q__------_-_-_--G 
Porcine NPY --SK_DN--ED-PA--L-R-YS-L--_I-__---__ 
Porcine PYY - - AK_-A--ED____ELSR-Y-SL-__L__V_____ 
Alligator PP T-L--KY--DG-PV--LIQFYDDLQQ-L-VV--P-F-NH2 
Chicken PP G-S--TY--DD-PV--LIRFYDNLQQ-L-VV--H-- 
Human PP A-LE-VY--D--T--QM-Q-A-DLRR-I-XL--P-- 
Abbreviations and references are given in the text. Dashes indicate identical residues to the corresponding sculpin 
peptides. In somatostatin residues 17 and 28 are disulphide-linked. With the exception of anglerfish aPY, the other 
members of the pancreatic polypeptide family all possess an amidated C-terminus at residue 36 
latter [14]. It appears from the residues conserved 
in the sequence that the basic folding pattern of 
turkey PP, as determined crystallographically [22], 
can be maintained for SPY as has been shown for 
NPY and PPY [15]. The dimerising surface shows 
an interesting substitution at position 21, where 
His replaces Tyr, but the hydrophobic interactions 
are preserved with Pro-14, Trp-17, Val-24 and 
Val-28 replacing Val, Leu, Leu and Leu, respec- 
tively. 
There are 14 changes in sequence from both por- 
cine NPY (brain) and porcine PPY (intestine) but 
considerably more differences exist with respect o 
the pancreatic polypeptides (see table 1). The ques- 
tion of whether SPY, and aPY, are new members 
of the PP family remains open until specific 
biological roles for all of these peptides can be 
clearly established. 
A fuller understanding of specific prohormone 
processing pathways will be greatly aided by 
crystallographic investigations of the prohormones 
60 
in addition to characterisation of the proteolytic 
enzymes involved. 
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